Status:
COMPLETED
S90652 in Paediatric Hypertension
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Hypertension
Eligibility:
All Genders
30-17 years
Phase:
PHASE2
Brief Summary
The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children
Eligibility Criteria
Inclusion
- Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy
Exclusion
- Poorly controlled hypertension
- Girls with signs of pubescence
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00202592
Start Date
November 1 2003
End Date
April 1 2010
Last Update
April 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker Enfants Malades
Paris, France